CHU de Nice, Hôpital de l'Archet 2

Nice 6200

0 studies enrolling now · 2 studies all time

What they study most

Compensated Cirrhosis, Metastatic Melanoma, Nonalcoholic Steatohepatitis, Unresectable Melanoma

Studies at this site

• IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18) — Running, not enrolling
• Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis — Completed